Meeting Rafaèle Tordjman from the investment fund Jeito
The Future4care team had the opportunity to exchange with Dr Rafaèle Tordjman, founder of the investment fund Jeito.
Published on January 12th, 2022, at 08:50 AM
A video interview to discover at the end of this article. 5 key facts Dr. Rafaèle Tordjman :
Rafaèle Tordjman is a Hemato-Oncology physician and scientist by training, with a PhD in Molecular Biology and Immunology.
Drawing on this experience, Dr. Tordjman has been investing in biotech for over 20 years, and has sat on the boards of some of its companies. These investments have generated five approved products and around 20 drugs in late-stage clinical development.
In 2018, Dr. Tordjman founded Jeito Capital, an independent investment company dedicated to biotech, to establish a continuous funding model and invest in the next generation of leaders in medical innovation. Her ambition is driven by a deep knowledge of the healthcare sector, and of biotech in particular. In creating this fund, Dr. Tordjman has once again demonstrated the importance of collaboration between the various players in the healthcare sector. Jeito raised 534 million euros ($630 million) in September 2021, becoming Europe's largest independent life sciences fund.
In July 2021, Dr. Tordjman was appointed by French President Emmanuel Macron to promote the French biotech ecosystem to major international players. Her mission is to attract healthcare and medical innovation talent to the French ecosystem.
Dr. Tordjman supports Future4care in its vocation to bring the ecosystem together to create a more cohesive healthcare system, with a view to the emergence of tomorrow's e-health solutions. "What is still to improve is how to work together, within an ecosystem, instead of working by silo. [...] It's exactly what Future4care wants to do".
At Future4care, we're convinced that initiatives like Jeito will help make our healthcare system robust and sustainable. Our vocation is to federate them as a trusted third party to accelerate progress in digital healthcare.
Discover the full interview of Docteur Rafaèle Tordjman.
